KIP Infrastructure
2.12.0 - ci-build
KIP Infrastructure, published by Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S. This guide is not an authorized publication; it is the continuous build for version 2.12.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/KIP-infrastructure/implementation-guide/ and changes regularly. See the Directory of published versions
| Official URL: https://kip.rkkp.dk/fhir/ValueSet/TreatmentRegimen | Version: 2.12.0 | |||
| Active as of 2022-07-13 | Computable Name: TreatmentRegimen | |||
Behandlingsplan som beskriver specifikke codsering og planlægningen af behandling
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen| Code | Display | Definition |
| hydrea | Hydrea | Hydrea |
| hdara_c | HdAraC | Hd-Ara-c +- supplement |
| da31087 | DA inkl. 3+10, 3+8, 3+7 | DA inkl. 3+10, 3+8, 3+7 |
| da31087my | DA inkl. 3+10, 3+8, 3+7 + mylotarg | DA inkl. 3+10, 3+8, 3+7 + mylotarg |
| da31087mi | DA inkl. 3+10, 3+8, 3+7 + midostaurin | DA inkl. 3+10, 3+8, 3+7 + midostaurin |
| flagmito | FLAG-Ida eller lign inkl FLAG, Mito-FLAG | FLAG-Ida eller lign inkl FLAG, Mito-FLAG |
| flagmitovene | FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax | FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax |
| idarac | IdAraC | IdAraC |
| apl_mt | APL vedligehold | APL-vedligeholdsbehandling |
| azacitidinmono | Azacitidin monoterapi | Azacitidin monoterapi |
| blinatumomab | Blinatumunab | Blinatumomab |
| vyxeos | Vyxeos | Vyxeos +- supplement |
| nopho_2008 | NOPHO 2008 | NOPHO-2008 |
| atoatra | ATO+ATRA | ATO+ATRA |
| aida | AIDA | AIDA |
| azacitidinvene | Azacitidin-venetoclax | Azacitidin-venetoclax |
| toplusfem | 2+5 eller lign, eks. CT | 2+5 eller lign, eks. CT |
| gilteritinib | Gilteritinib | Gilteritinib |
| midostaurin_ved | Midostaurin vedligehold | Midostaurin vedligehold |
| inotuzumab | Inotuzumab ozogamicin | Inotuzumab ozogamicin |
| all_ved | ALL vedligehold | ALL vedligehold |
| hyper_cvad | Hyper-CVAD | Hyper-CVAD |
| alltogether_mt | ALLtogether | ALLtogether |
| other_ikke | Anden ikke-intensiv | Anden ikke-intensiv |
| other_eks | Anden eksperimentel | Anden eksperimentel |
| other_semi | Anden semiintensiv (f.eks. Plan B) | Anden semiintensiv (f.eks. Plan B) |
| other_int | Anden intensiv (f.eks. BISHOP, Plan A) | Anden intensiv (f.eks. BISHOP, Plan A) |
Expansion performed internally based on codesystem Treatment regimen v2.12.0 (CodeSystem)
This value set contains 27 concepts
| Code | System | Display | Definition |
| hydrea | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | Hydrea | Hydrea |
| hdara_c | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | HdAraC | Hd-Ara-c +- supplement |
| da31087 | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | DA inkl. 3+10, 3+8, 3+7 | DA inkl. 3+10, 3+8, 3+7 |
| da31087my | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | DA inkl. 3+10, 3+8, 3+7 + mylotarg | DA inkl. 3+10, 3+8, 3+7 + mylotarg |
| da31087mi | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | DA inkl. 3+10, 3+8, 3+7 + midostaurin | DA inkl. 3+10, 3+8, 3+7 + midostaurin |
| flagmito | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | FLAG-Ida eller lign inkl FLAG, Mito-FLAG | FLAG-Ida eller lign inkl FLAG, Mito-FLAG |
| flagmitovene | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax | FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax |
| idarac | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | IdAraC | IdAraC |
| apl_mt | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | APL vedligehold | APL-vedligeholdsbehandling |
| azacitidinmono | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | Azacitidin monoterapi | Azacitidin monoterapi |
| blinatumomab | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | Blinatumunab | Blinatumomab |
| vyxeos | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | Vyxeos | Vyxeos +- supplement |
| nopho_2008 | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | NOPHO 2008 | NOPHO-2008 |
| atoatra | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | ATO+ATRA | ATO+ATRA |
| aida | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | AIDA | AIDA |
| azacitidinvene | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | Azacitidin-venetoclax | Azacitidin-venetoclax |
| toplusfem | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | 2+5 eller lign, eks. CT | 2+5 eller lign, eks. CT |
| gilteritinib | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | Gilteritinib | Gilteritinib |
| midostaurin_ved | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | Midostaurin vedligehold | Midostaurin vedligehold |
| inotuzumab | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | Inotuzumab ozogamicin | Inotuzumab ozogamicin |
| all_ved | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | ALL vedligehold | ALL vedligehold |
| hyper_cvad | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | Hyper-CVAD | Hyper-CVAD |
| alltogether_mt | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | ALLtogether | ALLtogether |
| other_ikke | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | Anden ikke-intensiv | Anden ikke-intensiv |
| other_eks | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | Anden eksperimentel | Anden eksperimentel |
| other_semi | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | Anden semiintensiv (f.eks. Plan B) | Anden semiintensiv (f.eks. Plan B) |
| other_int | https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen | Anden intensiv (f.eks. BISHOP, Plan A) | Anden intensiv (f.eks. BISHOP, Plan A) |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |